0 التعليقات
0 المشاركات
803 مشاهدة
0 معاينة
البحث
إكتشاف أشخاص جدد وإنشاء اتصالات جديدة وصداقات جديدة
-
الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
-
Digital Therapeutics Market Analysis: Growth Drivers, Market Trends and Forecast"Global Executive Summary Digital Therapeutics Market: Size, Share, and Forecast Data Bridge Market Research analyses that the global digital therapeutics market which was USD 4,300.00 million in 2022, expected to reach USD 20,421.08 million by 2030, and is expected to undergo a CAGR of 21.5% during the forecast period 2023-2030. The report has provided crucial information about the...0 التعليقات 0 المشاركات 655 مشاهدة 0 معاينة
-
Digital Therapeutics market Future Outlook and Growth Potential Report"Digital Therapeutics Market Summary: According to the latest report published by Data Bridge Market Research, the Digital Therapeutics Market Data Bridge Market Research analyses that the global digital therapeutics market which was USD 4,300.00 million in 2022, expected to reach USD 20,421.08 million by 2030, and is expected to undergo a CAGR of 21.5% during the forecast period...0 التعليقات 0 المشاركات 398 مشاهدة 0 معاينة
-
Digital Therapeutics Market Research Report: Industry Trends, Demand and Future Outlook"Key Drivers Impacting Executive Summary Digital Therapeutics Market Size and Share Data Bridge Market Research analyses that the global digital therapeutics market which was USD 4,300.00 million in 2022, expected to reach USD 20,421.08 million by 2030, and is expected to undergo a CAGR of 21.5% during the forecast period 2023-2030. The Digital Therapeutics Market report contains...0 التعليقات 0 المشاركات 519 مشاهدة 0 معاينة
-
Lung Transplant Therapeutics Market Growth and Future TrendsLung Transplant Therapeutics Market Summary: According to the latest report published by Data Bridge Market Research, the Lung Transplant Therapeutics Market CAGR Value The global lung transplant therapeutics market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 4.8% in the...0 التعليقات 0 المشاركات 358 مشاهدة 0 معاينة
-
Microbiome-Based Therapeutics Market Forecast: Industry Size, Share, and Future Trends"Global Executive Summary Microbiome-Based Therapeutics Market: Size, Share, and Forecast The global Microbiome-Based Therapeutics market size was valued at USD 3.17 billion in 2024 and is expected to reach USD 18.29 billion by 2032, at a CAGR of 24.50% during the forecast period This Microbiome-Based Therapeutics Market research report contains specific...0 التعليقات 0 المشاركات 651 مشاهدة 0 معاينة
-
Nucleic Acid-Based Therapeutics Market Outlook: Growth Trends & Market Opportunities"Executive Summary Nucleic Acid-Based Therapeutics Market Size and Share Analysis Report The global nucleic acid-based therapeutics market size was valued at USD 4.94 billion in 2024 and is expected to reach USD 14.38 billion by 2032, at a CAGR of 14.29% during the forecast period This Nucleic Acid-Based Therapeutics Market report is useful in evaluating...0 التعليقات 0 المشاركات 634 مشاهدة 0 معاينة
-
Probiotic-Based Vaginal Therapeutics Market Demand Analysis & Strategic Business OpportunitiesAccording to the latest report published by Data Bridge Market Research, the Probiotic-Based Vaginal Therapeutics Market The global probiotic-based vaginal therapeutics market size was valued at USD 654.23 million in 2024 and is expected to reach USD 1,194.88 million by 2032, at a CAGR of 7.82% during the forecast period This world-wide Probiotic-Based Vaginal Therapeutics Market...0 التعليقات 0 المشاركات 24 مشاهدة 0 معاينة
-
Rare Pediatric Epilepsy Therapeutics market Competitive Analysis Report for Leading Companies"Rare Pediatric Epilepsy Therapeutics Market Summary: According to the latest report published by Data Bridge Market Research, the Rare Pediatric Epilepsy Therapeutics Market The global rare pediatric epilepsy therapeutics market size was valued at USD 198.00 Million in 2025 and is expected to reach USD 466.90 Million by 2033, at a CAGR of 11.32% during the forecast period The data,...0 التعليقات 0 المشاركات 190 مشاهدة 0 معاينة
-
Selective Estrogen Receptor Degraders (SERD) Therapeutics Market Dynamics: Key Drivers and Restraints 2025 –2032Executive Summary Selective Estrogen Receptor Degraders (SERD) Therapeutics Market: Share, Size & Strategic Insights CAGR Value The global Selective Estrogen Receptor Degraders (SERD) therapeutics market size was valued at USD 4.80 billion in 2025 and is expected to reach USD 16.46 billion by 2033, at a CAGR of 16.66% during the forecast period The key...0 التعليقات 0 المشاركات 463 مشاهدة 0 معاينة
-
(R)-Homopipecolic Acid Market Projected at USD 52.6M by 2034: Chiral Non-Proteinogenic Amino Acid Unlocks Next-Gen CNS Therapeutics at 7.2% CAGRGlobal (R)-Homopipecolic acid market was valued at USD 28.4 million in 2025. The market is projected to grow from USD 30.1 million in 2026 to USD 52.6 million by 2034, exhibiting a remarkable CAGR of 7.2% during the forecast period. (R)-Homopipecolic acid is a non-proteinogenic amino acid and a chiral building block characterized by its six-membered nitrogen-containing ring structure. As an...0 التعليقات 0 المشاركات 260 مشاهدة 0 معاينة
-
(R)-Nipecotic Acid Ethyl Ester Market Size & Forecast 2034 | Chiral Pharmaceutical Intermediate for CNS Drugs, GABA Uptake Inhibitors & Neurological TherapeuticsGlobal (R)-Nipecotic acid ethyl ester market was valued at USD 18.6 million in 2025 and is projected to reach USD 34.2 million by 2034, exhibiting a remarkable CAGR of 7.1% during the forecast period. (R)-Nipecotic acid ethyl ester is a specialized chiral pharmaceutical intermediate derived from nipecotic acid, valued for its role as a selective GABA uptake inhibitor. It has transitioned...0 التعليقات 0 المشاركات 249 مشاهدة 0 معاينة
-
Adult Malignant Glioma Therapeutics Market Graph: Growth, Share, Value, Insights, and Trends1. Introduction Adult malignant gliomas are among the most aggressive and lethal cancers of the central nervous system. Originating in the glial cells of the brain, these tumors are characterized by rapid progression, high recurrence rates, and limited long-term survival outcomes. The most common and severe type, glioblastoma multiforme (GBM), remains extremely challenging to treat, despite...0 التعليقات 0 المشاركات 1كيلو بايت مشاهدة 0 معاينة
-
Adult Malignant Glioma Therapeutics Market Growth Drivers: Share, Value, Size, and Insights"Executive Summary Adult Malignant Glioma Therapeutics Market Research: Share and Size Intelligence Global adult malignant glioma therapeutics market size was valued at USD 2.63 billion in 2024 and is projected to reach USD 5.43 billion by 2032, with a CAGR of 9.50% during the forecast period of 2025 to 2032. Adult Malignant Glioma Therapeutics Market report makes available the...0 التعليقات 0 المشاركات 1كيلو بايت مشاهدة 0 معاينة
-
Adult Malignant Glioma Therapeutics Market Industry Statistics: Growth, Share, Value, Insights, and Trends"Market Trends Shaping Executive Summary Adult Malignant Glioma Therapeutics Market Size and Share Global adult malignant glioma therapeutics market size was valued at USD 2.63 billion in 2024 and is projected to reach USD 5.43 billion by 2032, with a CAGR of 9.50% during the forecast period of 2025 to 2032. Adult Malignant Glioma Therapeutics Market report performs geographical...0 التعليقات 0 المشاركات 961 مشاهدة 0 معاينة
-
Adult Malignant Glioma Therapeutics Market Scope: Growth, Share, Value, Size, and Trends"Executive Summary Adult Malignant Glioma Therapeutics Market Market Size and Share Across Top Segments CAGR Value Global adult malignant glioma therapeutics market size was valued at USD 2.63 billion in 2024 and is projected to reach USD 5.43 billion by 2032, with a CAGR of 9.50% during the forecast period of 2025 to 2032. Adult Malignant Glioma Therapeutics Market Market report has...0 التعليقات 0 المشاركات 2كيلو بايت مشاهدة 0 معاينة
-
Adult Malignant Glioma Therapeutics Market: Comprehensive Analysis and Future OutlookIntroduction Adult malignant glioma represents one of the most aggressive and lethal forms of primary brain tumors, posing a significant clinical and economic burden worldwide. Characterized by rapid progression, invasive growth, and limited responsiveness to conventional therapies, malignant gliomas—particularly glioblastoma—continue to challenge oncologists and neuroscientists...0 التعليقات 0 المشاركات 1كيلو بايت مشاهدة 0 معاينة
-
Advance Renal Cell Carcinoma Therapeutics Market Growth, Revenue Analysis Industry Outlook, ForecastAnalysis By FMINEWARK, Del., USA | April 16, 2026 — According to the latest insights by Future Market Insights, the global advance renal cell carcinoma therapeutics market is entering a steady growth trajectory as oncology treatment paradigms evolve toward combination regimens. The market is valued at USD 7.80 billion in 2026 and is projected to reach USD 13.20 billion by 2036, expanding at a CAGR of...0 التعليقات 0 المشاركات 514 مشاهدة 0 معاينة
الصفحات المعززة
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek